Preventive Effects of Dipeptidyl Peptidase-4 Inhibitor on Angiotensin II-induced Cardiac Hypertrophy Independent of Incretin Signaling in ApoE Null Mice

被引：0
|
作者：
Hiromura, Munenori
Kohashi, Kyoko
Mori, Yusaku
Terasaki, Michishige
Kushima, Hideki
Nagashima, Masaharu
Shinmura, Kyoko
Tomoyasu, Masako
Watanabe, Takuya
Hirano, Tsutomu
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
523-P
引用
收藏
页码：A135 / A135
页数：1
相关论文
共 50 条
  • [1] Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice
    Brown, Scott M.
    Smith, Cassandra E.
    Meuth, Alex I.
    Khan, Maloree
    Aroor, Annayya R.
    Cleeton, Hannah M.
    Meininger, Gerald A.
    Sowers, James R.
    DeMarco, Vincent G.
    Chandrasekar, Bysani
    Nistala, Ravi
    Bender, Shawn B.
    ENDOCRINOLOGY, 2017, 158 (10) : 3592 - 3604
  • [2] Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
    Terasaki, Michishige
    Nagashima, Masaharu
    Nohtomi, Kyoko
    Kohashi, Kyoko
    Tomoyasu, Masako
    Sinmura, Kyoko
    Nogi, Yukinori
    Katayama, Yuki
    Sato, Kengo
    Itoh, Fumiko
    Watanabe, Takuya
    Hirano, Tsutomu
    PLOS ONE, 2013, 8 (08):
  • [3] A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice
    Kohashi, Kyoko
    Hiromura, Munenori
    Mori, Yusaku
    Terasaki, Michishige
    Watanabe, Takuya
    Kushima, Hideki
    Shinmura, Kyoko
    Tomoyasu, Masako
    Nagashima, Masaharu
    Hirano, Tsutomu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (04) : 441 - 454
  • [4] The dipeptidyl peptidase IV inhibitor saxagliptin prevents angiotensin II-induced cardiac diastolic dysfunction: potential involvement of cardiac lymphocytes?
    Brown, Scott M.
    Smith, Cassandra E.
    Khan, Maloree
    Meuth, Alex I.
    Sowers, James R.
    Chandrasekar, Bysani
    DeMarco, Vincent G.
    Nistala, Ravi
    Bender, Shawn B.
    FASEB JOURNAL, 2017, 31
  • [5] Renoprotective effects of incretin-based drugs: A novel pleiotropic effect of dipeptidyl peptidase-4 inhibitor
    Kodera, Ryo
    Shikata, Kenichi
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (01) : 29 - 31
  • [6] Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice
    Choi, Seung Hee
    Leem, Jaechan
    Lee, In-Kyu
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [7] Cardioprotective Effects of Dipeptidyl Peptidase-4 Inhibitor on Pressure Overload-induced Heart Failure in Mice
    Kobara, Yuka
    Hasegawa, Hiroshi
    Kameda, Yoshihito
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S157 - S157
  • [8] Cardioprotective Effects of Dipeptidyl Peptidase-4 Inhibitor on Diabetes Mice after Myocardial Infarction
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kobara, Yuka
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S179 - S180
  • [9] Effects of Dipeptidyl Peptidase-4 Inhibitor and Angiotensin-Converting Enzyme Inhibitor on Experimental Diabetic Kidney Disease
    Al Tuhaifi, Tareq
    Zhong, Jianyong
    Yang, Hai-Chun
    Fogo, Agnes B.
    LABORATORY INVESTIGATION, 2024, 104 (02)
  • [10] Renoprotective Effect of Sitagliptin (Dipeptidyl Peptidase-4 Inhibitor) aganist Cisplatin Induced Nephrotoxicity in Mice
    Shalaby, Amany
    Malek, Hala Abdel
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 4 (09): : 1116 - 1129
12345